Consumer Goods & Retail Global On demand · 24-48h

Global Fish Oil Supplements for Dogs Market Strategic Research Report

Global Fish Oil Supplements for Dogs Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Fish Oil Supplements for Dogs Market
$9442025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Liquid, Capsule, Others

By Application: Online Sales, Veterinary Hospital, Vet Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Icelandirect, Skipper's Pet Products, Nutramax Laboratories, Zesty Paws, Pet Honesty, Now Food, EicosaDerm(Dechra), VetriScience, Native Pet, NaturVet(Swedencare), Nordic Naturals, Grizzly Pet, Alaska Naturals(Trident Seafoods), Nutri-Vet, Natural Dog Company, Vetoquinol, Virbac, Blackmores, Beaphar, Canina Pharma, Gambol Pet Group Co., Ltd., RedDog, NOURSE, Japan Pet Health & Care Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 151 pages
Market size 2025
$944
Million USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$1447.8
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Fish Oil Supplements for Dogs market size is predicted to grow from US$ 944 million in 2025 to US$ 1,445 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

In 2025, the global production of fish oil supplements for dogs reached approximately 48,200 tons, with an average global market price of around US$20,000/ton. In the same year, the global total production capacity of fish oil supplements for dogs reached 60,250 tons. The industry average gross profit margin of this product reached 45%.Fish oil supplements for dogs are functional pet nutritional supplements specifically developed to meet the nutritional and health needs of canines. They primarily use marine lipids such as deep-sea fish oil, salmon oil, cod liver oil, and krill oil as core ingredients, and are rich in Omega-3 fatty acids (EPA and DHA). These supplements help improve skin and coat health, reduce inflammation, promote joint function, support cardiovascular health, and strengthen the immune system. The products are typically available in liquid oils, softgels, chewable tablets, gummies, and powders, and are widely used in puppy growth, adult dog health care, and chronic disease management in senior dogs. This is one of the fastest-growing segments in the current pet nutrition and health supplement market.

The upstream of the fish oil supplements for dogs industry chain mainly includes deep-sea fish fishing companies, seafood processing companies, fish oil refining companies, Omega-3 concentration technology suppliers, and packaging material suppliers. Core raw material sources include marine resources such as anchovies, sardines, mackerel, salmon, and krill. The midstream consists of pet nutrition manufacturers who produce fish oil products of different specifications using technologies such as molecular distillation, deodorization, concentration and purification, and microencapsulation, and complete formula development, filling and packaging, and brand operation. The downstream includes pet hospitals, pet chain stores, e-commerce platforms, cross-border e-commerce, and pet subscription service platforms, ultimately selling to canine consumers. With the increasing trend of anthropomorphizing pets, the industry chain is upgrading towards high-purity Omega-3, Sustainable Fisheries Certification (MSC), natural organic, and functional compound formulas.

In the future, the fish oil supplements for dogs market will continue to benefit from global pet anthropomorphism, the upgrading of high-end pet food consumption, and the growing demand for canine chronic disease management. More and more pet owners are treating their pets as family members, and are increasing their investment in joint health, skin care, immune system enhancement, and senior dog care, making fish oil one of the most popular pet nutritional supplements. Meanwhile, increased veterinary recommendations, the expansion of e-commerce sales channels, and the growing trend towards natural health products are further driving market growth. The Asia-Pacific region, especially China, Japan, and Southeast Asia, is experiencing significantly faster growth than mature markets in Europe and the United States, and the global market is expected to maintain medium-to-high-speed growth in the coming years.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fish Oil Supplements for Dogs market?

What factors are driving Fish Oil Supplements for Dogs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fish Oil Supplements for Dogs market opportunities vary by end market size?

How does Fish Oil Supplements for Dogs break out by Type, by Application?

This report presents a comprehensive overview of the global Fish Oil Supplements for Dogs market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Liquid
  • Capsule
  • Others

Segment by Ingredient Sources

  • Salmon Oil
  • Cod Liver Oil
  • Tuna Oil
  • Sardine Oil
  • Krill Oil
  • Mixed Marine Fish Oil

Segment by Age Specific

  • Puppy-Specific
  • Adult-Specific
  • Senior-Specific
  • Suitable for All Ages

Segment by Application

  • Online Sales
  • Veterinary Hospital
  • Vet Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Fish Oil Supplements for Dogs market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Online Sales, Veterinary Hospital, Vet Clinic evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Fish Oil Supplements for Dogs Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$944
2025
Forecast
$1447.8
2032
CAGR
6.3%
2025–2032
Области
5
global
Key companies
IcelandirectSkipper's Pet ProductsNutramax LaboratoriesZesty PawsPet HonestyNow FoodEicosaDerm(Dechra)VetriScience
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
LiquidCapsuleOthers
By Application
Online SalesVeterinary HospitalVet ClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Liquid
  • 3.1.3 Capsule
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Online Sales
  • 4.1.3 Veterinary Hospital
  • 4.1.4 Vet Clinic
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Icelandirect
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Skipper's Pet Products
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nutramax Laboratories
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zesty Paws
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Pet Honesty
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Now Food
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 EicosaDerm(Dechra)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 VetriScience
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Native Pet
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 NaturVet(Swedencare)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Nordic Naturals
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Grizzly Pet
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Alaska Naturals(Trident Seafoods)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Nutri-Vet
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Natural Dog Company
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Vetoquinol
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Virbac
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Blackmores
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Beaphar
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Canina Pharma
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Gambol Pet Group Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 RedDog
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 NOURSE
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Japan Pet Health & Care Co., Ltd.
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Fish Oil Supplements for Dogs market size?
The global Fish Oil Supplements for Dogs market is estimated at US$ 944 million in 2025 (base year) and is projected to reach US$ 1.45 billion by 2032.
What growth rate is expected for the Fish Oil Supplements for Dogs market through 2032?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 944 million in 2025 to US$ 1.45 billion in 2032, roughly 1.5 times its base-year value.
How is Fish Oil Supplements for Dogs defined?
In 2025, the global production of fish oil supplements for dogs reached approximately 48,200 tons, with an average global market price of around US$20,000/ton. In the same year, the global total production capacity of fish oil supplements for dogs reached 60,250 tons. The industry average gross profit margin of this product reached 45%.Fish oil supplements for dogs are functional pet nutritional supplements specifically developed to meet the nutritional and health needs of canines.
What are the main segments of the Fish Oil Supplements for Dogs market by type?
By type, the market is segmented into Liquid, Capsule and Others.
Which applications drive demand in the Fish Oil Supplements for Dogs market?
Key applications covered include Online Sales, Veterinary Hospital, Vet Clinic and Others.
Who are the key players in the Fish Oil Supplements for Dogs market?
Key players profiled include Icelandirect, Skipper's Pet Products, Nutramax Laboratories, Zesty Paws, Pet Honesty, Now Food, EicosaDerm(Dechra) and VetriScience, among 24 companies covered in total.
Which regions and countries are covered for Fish Oil Supplements for Dogs?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Fish Oil Supplements for Dogs market?
Meanwhile, increased veterinary recommendations, the expansion of e-commerce sales channels, and the growing trend towards natural health products are further driving market growth.
Who should buy the Fish Oil Supplements for Dogs market report?
The report is intended for manufacturers and solution providers, distributors and end users in Online Sales, Veterinary Hospital and Vet Clinic, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Fish Oil Supplements for Dogs market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.